Feature Image

Medical Marijuana Inc.’s HempMedsPX Joins A4M as Platinum Elite Sponsor

HempMedsPX to Participate in the American Academy of Anti-Aging Medicine’s (A4M) 2014 Conferences; Awareness of CBD-Rich Hemp Oil Products Reaches More Than 26,000 Members

SAN DIEGO, Feb. 19, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) and HempMedsPX™ – a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. – are pleased to announce that the American Academy of Anti-Aging Medicine (A4M) has approved and is actively promoting HempMedsPX™ as a new Platinum Elite Sponsor on both the A4M and Worldhealth.net websites. The A4M is a 501(c)3 non-profit organization with more than 26,000 members including physicians, scientists, and governmental officials in over 120 nations. The A4M seeks to disseminate information concerning innovative science and research as well as treatment modalities designed to prolong the human lifespan. The online information portal for the A4M members, Worldhealth.net, is a leading non-profit source of trusted, non-commercial health information for doctors and the general public.

The A4M is dedicated to the advancement of technology to detect, prevent, and treat aging-related disease, and to promote research into methods to slow and optimize the human aging process. The A4M is also dedicated to educating physicians, scientists, and members of the public on biomedical sciences, cutting-edge technologies, and anti-aging issues. 85% of A4M’s membership is physicians, and the organization is a destination for Board (The American Board of Anti-Aging and Regenerative Medicine – ABAARM) and Diplomate (The American Board of Anti-Aging Health Practitioners – ABAAHP) certifications, as well as a variety of additional Anti-Aging medicine accreditation programs for healthcare practitioners.

Cannabinoids have been found to have antioxidant properties. The US Department of Health and Human Services (HHS) was awarded United States Patent #6,630,507 for CBD and other cannabinoids on Oct. 7, 2003.

The greatest benefit of A4M Platinum Elite Sponsorship for Medical Marijuana Inc. and HempMedsPX™ is the access to governmental decision-makers, groundbreaking scientists, and innovative physicians who have the ability to medically and scientifically evaluate and recommend CBD-rich hemp oil products globally. A variety of market opportunities defined by the A4M include:

The anti-aging market is estimated to be worth $292 billion globally by 2015.
10% of the world’s population is aged 60+ today, and is expected to represent 22% by 2050.
The global nutraceutical market is projected to exceed $243 billion by 2015.
— The current US nutraceutical market is valued at $17.1 billion.
Sixty percent (60%) of Americans aged 65+ are pursuing anti-aging interventions, including hormone replacement therapies and dietary supplementation.
Dietary supplement sales were $25 billion in 2010.
— Thirty-three percent (33%) of adults take supplements on the specific advice of their doctor.
“CBD is recognized as a powerful antioxidant by the U.S. government’s patent on cannabidiol and other cannabinoids,” says Michelle Sides, COO of Medical Marijuana Inc. “HempMedsPX™ is blazing a trail as the front-runner in both the global anti-aging and nutraceutical markets by providing the A4M’s 26,000 doctors and scientists with the latest information on the antioxidant properties of the world’s purest and richest CBD hemp oil products. Our efforts to inform the public about CBD-rich hemp oil products are significantly accelerated through our newfound alliance with the A4M. We are extremely honored to be a Platinum Elite Sponsor of the A4M organization, and we look forward to actively participating in a full slate of conferences in 2014.”

Throughout the year, HempMedsPX™ will exhibit and promote cannabidiol (CBD)-rich hemp oil products to tens of thousands of A4M members at the organization’s conferences including:

March 13-16: BHRT Symposium / Fellowship – San Francisco
April 4-6: Commercial Workshop / BHRT Symposium / Fellowship – Denver
May 15-17: Commercial Workshop – Orlando
September 10-13: BHRT Symposium / Fellowship – Phoenix
October 16-18: Fellowship Modules and IV Symposium – New Orleans
December 11-13: Commercial Workshop – Las Vegas
The A4M is comprised of over 26,000 members from 120 nations worldwide, as follows:

85% are physicians (MD, DO, MBBS)
12% are scientists, researchers, and healthcare practitioners; and
3% are governmental officials, members of the working press and general public
The disciplines of the A4M physician members are approximately:

Family Practice, 23%
General Medicine, 15%
Endocrinology, 11%
Internal Medicine, 8%
Dermatology, 8%
Plastic Surgery, 6%
Cardiology, 8%
Doctors of Osteopathy (D.O.), 6%
OB-GYN, 5%
Sports Medicine, 4%
Orthopedics, 2%
Emergency Medicine, 2%
Doctors of Chiropractic (D.C.), 2%
HempMedsPX™ proudly represents the world’s first innovative lines of CBD-rich hemp oil products. On February 9th, HempMedsPX™ continued to establish the Company’s brand recognition by representing the winner of the globally-renowned 2014 High Times Cannabis Cup competition in Los Angeles for Highest CBD Concentrate. This extremely competitive international judging event featured entries by the most prominent growers, breeders and producers of cannabis and cannabis products. Other significant industry accolades include first place awards for Highest CBD Concentrate at the 2013 High Times Cannabis Cup competition in Amsterdam, the 2013 Seattle High Times Cannabis Cup, and the 2013 Michigan Medical Marijuana Conference “Green Cup” contests.

HempMedsPX™’s primary message to the public is that industrial hemp-derived CBD is non-psychoactive, is readily available online, and is legal throughout the United States and in more than forty countries. For more information on CBD-rich hemp oil products, please visit:

HempMedsPX
http://www.HempMedsPX.com
866.273.8502

Real Scientific Hemp Oil
http://RealScientificHempOil.com
866.273.8502

HempVAP
http://www.hempVAP.com
866.273.8502

Cibdex
http://www.cibdex.com
866.273.8502

Cibaderm
http://www.cibaderm.com
866.273.8502
About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com

About HempMedsPX

HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About CannaVest Corp.

CannaVest Corp. is in the business of investing and developing hemp-based businesses. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company’s supply international relationships.CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Investor relations contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc